Onconetix Stock Total Asset

ONCO Stock  USD 0.61  0.03  4.69%   
Onconetix fundamentals help investors to digest information that contributes to Onconetix's financial success or failures. It also enables traders to predict the movement of Onconetix Stock. The fundamental analysis module provides a way to measure Onconetix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Onconetix stock.
Last ReportedProjected for Next Year
Total Assets87.5 M91.9 M
Intangibles To Total Assets 0.83  0.74 
As of the 11th of December 2024, Total Assets is likely to grow to about 91.9 M, while Intangibles To Total Assets are likely to drop 0.74.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Onconetix Company Total Asset Analysis

Onconetix's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Total Asset

 = 

Tangible Assets

+

Intangible Assets

More About Total Asset | All Equity Analysis

Current Onconetix Total Asset

    
  87.52 M  
Most of Onconetix's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Onconetix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Onconetix Total Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for Onconetix is extremely important. It helps to project a fair market value of Onconetix Stock properly, considering its historical fundamentals such as Total Asset. Since Onconetix's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Onconetix's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Onconetix's interrelated accounts and indicators.
1.00.49-0.990.990.621.00.230.950.050.86-0.65-0.93-0.93-0.93-0.93
1.00.44-0.990.990.590.990.280.960.10.87-0.61-0.92-0.92-0.92-0.92
0.490.44-0.450.490.480.56-0.730.25-0.840.12-0.98-0.61-0.61-0.61-0.61
-0.99-0.99-0.45-1.0-0.69-0.99-0.26-0.97-0.09-0.90.610.90.90.90.9
0.990.990.49-1.00.691.00.230.960.040.86-0.65-0.93-0.93-0.93-0.93
0.620.590.48-0.690.690.67-0.050.65-0.150.62-0.54-0.53-0.53-0.53-0.53
1.00.990.56-0.991.00.670.150.94-0.030.83-0.71-0.94-0.94-0.94-0.94
0.230.28-0.73-0.260.23-0.050.150.470.970.490.58-0.09-0.09-0.09-0.09
0.950.960.25-0.970.960.650.940.470.30.92-0.43-0.85-0.85-0.85-0.85
0.050.1-0.84-0.090.04-0.15-0.030.970.30.40.720.130.130.130.13
0.860.870.12-0.90.860.620.830.490.920.4-0.3-0.63-0.63-0.63-0.63
-0.65-0.61-0.980.61-0.65-0.54-0.710.58-0.430.72-0.30.730.730.730.73
-0.93-0.92-0.610.9-0.93-0.53-0.94-0.09-0.850.13-0.630.731.01.01.0
-0.93-0.92-0.610.9-0.93-0.53-0.94-0.09-0.850.13-0.630.731.01.01.0
-0.93-0.92-0.610.9-0.93-0.53-0.94-0.09-0.850.13-0.630.731.01.01.0
-0.93-0.92-0.610.9-0.93-0.53-0.94-0.09-0.850.13-0.630.731.01.01.0
Click cells to compare fundamentals

Onconetix Total Asset Historical Pattern

Today, most investors in Onconetix Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Onconetix's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Onconetix total asset as a starting point in their analysis.
   Onconetix Total Asset   
       Timeline  
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Competition

Onconetix Total Assets

Total Assets

91.89 Million

At this time, Onconetix's Total Assets are very stable compared to the past year.
Based on the latest financial disclosure, Onconetix has a Total Asset of 87.52 M. This is 98.84% lower than that of the Biotechnology sector and 95.57% lower than that of the Health Care industry. The total asset for all United States stocks is 99.7% higher than that of the company.

Onconetix Total Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Onconetix's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Onconetix could also be used in its relative valuation, which is a method of valuing Onconetix by comparing valuation metrics of similar companies.
Onconetix is currently under evaluation in total asset category among its peers.

Onconetix Fundamentals

About Onconetix Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Onconetix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Onconetix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Onconetix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Onconetix

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Onconetix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Onconetix will appreciate offsetting losses from the drop in the long position's value.

Moving together with Onconetix Stock

  0.84VALN Valneva SE ADRPairCorr
  0.75ERNA Eterna TherapeuticsPairCorr

Moving against Onconetix Stock

  0.81BMY Bristol Myers SquibbPairCorr
  0.73GILD Gilead SciencesPairCorr
  0.72ESPR Esperion TherapeuticsPairCorr
  0.66DYAI Dyadic InternationalPairCorr
  0.33DNA Ginkgo Bioworks HoldingsPairCorr
The ability to find closely correlated positions to Onconetix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Onconetix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Onconetix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Onconetix to buy it.
The correlation of Onconetix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Onconetix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Onconetix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Onconetix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Onconetix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Onconetix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Onconetix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Onconetix Stock:
Check out Onconetix Piotroski F Score and Onconetix Altman Z Score analysis.
To learn how to invest in Onconetix Stock, please use our How to Invest in Onconetix guide.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Onconetix. If investors know Onconetix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Onconetix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(109.20)
Revenue Per Share
2.892
Return On Assets
(0.22)
Return On Equity
(17.58)
The market value of Onconetix is measured differently than its book value, which is the value of Onconetix that is recorded on the company's balance sheet. Investors also form their own opinion of Onconetix's value that differs from its market value or its book value, called intrinsic value, which is Onconetix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Onconetix's market value can be influenced by many factors that don't directly affect Onconetix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Onconetix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Onconetix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Onconetix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.